Walleye Capital’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Other funds holding MRNA
TP
Walleye Capital's MRNA Position: Q3 2026 in Review
Walleye Capital increased its Moderna (MRNA) stake by 2,284% in Q3 2026, buying an estimated $1.92M and bringing the position to 18,621 shares worth $3.59M. The position accounts for ﹤0.01% of the portfolio, ranked #2240.
Walleye Capital first reported a position in MRNA in Q2 2019 and has held it in 15 quarters since. The position peaked at $8.79M in Q1 2025. 967 funds tracked by Wall St. Rank hold MRNA as of Q3 2026.
- Walleye Capital held 18,621 shares of Moderna worth $3.59M as of Q3 2026.
- Walleye Capital bought 17,840 Moderna shares in Q3 2026, an estimated $1.92M.
- Moderna made up ﹤0.01% of Walleye Capital's portfolio in Q3 2026, its #2240 holding.
- Walleye Capital first reported a position in Moderna in Q2 2019 and has held it in 15 quarters since.
- Walleye Capital's Moderna position peaked at $8.79M in Q1 2025.
- 967 funds tracked by Wall St. Rank held Moderna as of Q3 2026.
Based on Walleye Capital's 13F filing for Q3 2026, filed 13 Nov 2026.